{"id":"NCT03220958","sponsor":"Montefiore Medical Center","briefTitle":"Metoclopramide for Post Traumatic Headache","officialTitle":"A Randomized Placebo Controlled Trial of IV Metoclopramide for Acute Post-traumatic Headache","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-08-01","primaryCompletion":"2020-04-01","completion":"2020-04-01","firstPosted":"2017-07-18","resultsPosted":"2021-11-09","lastUpdate":"2021-11-09"},"enrollment":160,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Post-Traumatic Headache"],"interventions":[{"type":"DRUG","name":"Metoclopramide","otherNames":[]},{"type":"DRUG","name":"Diphenhydramine","otherNames":[]},{"type":"DRUG","name":"Normal saline","otherNames":[]}],"arms":[{"label":"Metoclopramide","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Nearly 1.5 million patients present to US emergency departments annually following head trauma. Headache is a frequent symptom of victims of head trauma. The purpose of this study is to see if an intravenous medication called metoclopramide can improve the symptoms of patients with acute post-traumatic headache.","primaryOutcome":{"measure":"0-10 Pain Scale on Which 0 = no Pain and 10= the Worst Pain Imaginable","timeFrame":"1 hour after medication administration","effectByArm":[{"arm":"Metoclopramide","deltaMin":5.2,"sd":2.3},{"arm":"Placebo","deltaMin":3.8,"sd":2.6}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["33762421"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":81},"commonTop":["Drowsiness","Post-concussive syndrome","Various other","Akathisia","Dizziness"]}}